ExodusPoint Capital Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,976
| Closed | -$193K | – | 1650 |
|
|
2025
Q1 | $193K | Buy |
+18,976
| New | +$193K | ﹤0.01% | 1243 |
|
|
2024
Q3 | – | Sell |
-19,940
| Closed | -$911K | – | 1727 |
|
|
2024
Q2 | $911K | Buy |
+19,940
| New | +$911K | 0.01% | 933 |
|
|
2023
Q1 | – | Sell |
-11,823
| Closed | -$568K | – | 1857 |
|
|
2022
Q4 | $568K | Buy |
+11,823
| New | +$568K | 0.01% | 1095 |
|
|
2021
Q4 | – | Sell |
-15,952
| Closed | -$631K | – | 2337 |
|
|
2021
Q3 | $631K | Buy |
+15,952
| New | +$631K | 0.01% | 1216 |
|